Renyi Yang
Impact in
-
- Ferroptosis and cancer prognosis
-
- Natural Compounds in Disease Treatment
- Traditional Chinese Medicine Analysis
Papers in
-
- Ferroptosis and cancer prognosis 11
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- Puhua Zeng (17 shared papers)Wenhui Gao (3 shared papers)Zhibing Wang (3 shared papers)Wei Peng (1 shared paper)Xiaopeng Yu (5 shared papers)Lijuan Liu (2 shared papers)Jincheng Tang (8 shared papers)Xiaoning Tan (3 shared papers)
- Journals
- Phytomedicine (4 papers)Journal of Ethnopharmacology (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Frontiers in Pharmacology (2 papers)Natural Product Communications (2 papers)
- Partner nations
- China
In The Last Decade
Renyi Yang
25 papers receiving 266 citations
Renyi Yang's Hit Papers
Peers
Comparison fields: 5 of 55
- Pulmonary and Respiratory Medicine 119
- Complementary and alternative medicine 22
- Hepatology 13
- Reproductive Medicine 14
- Cancer Research 14
Countries citing papers authored by Renyi Yang
This map shows the geographic impact of Renyi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renyi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renyi Yang more than expected).
Fields of papers citing papers by Renyi Yang
This network shows the impact of papers produced by Renyi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renyi Yang. The network helps show where Renyi Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Renyi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis Hit paper breakdown → | 2023 | 187 |
| 2 | 2024 | 14 | |
| 3 | 2025 | 6 | |
| 4 | 2025 | 6 | |
| 5 | 2023 | 5 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2025 | 4 | |
| 10 | 2025 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2024 | 3 | |
| 13 | 2024 | 3 | |
| 14 | 2025 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 2 |
About Renyi Yang
Renyi Yang is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Oncology, Genetics and Cancer Research, having authored 32 papers that have together received 271 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Genetic Associations and Epidemiology (5 papers), Global Cancer Incidence and Screening (2 papers), Computational Drug Discovery Methods (2 papers), Natural Compounds in Disease Treatment (2 papers), Extracellular vesicles in disease (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (119 citations), Complementary and alternative medicine (22 citations), Hepatology (13 citations), Reproductive Medicine (14 citations) and Cancer Research (14 citations). Renyi Yang has collaborated with scholars based in China. Frequent co-authors include Puhua Zeng, Wenhui Gao, Zhibing Wang, Wei Peng, Xiaopeng Yu, Lijuan Liu, Jincheng Tang, Xiaoning Tan, Wei Peng and Weidong Zhang. Their work appears in journals such as Phytomedicine, Journal of Ethnopharmacology, Journal of Cancer Research and Clinical Oncology, Frontiers in Pharmacology and Natural Product Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.